PRESENTED BY DR. JALAL MOKHALALATI, B.SC., M.SC., PH.D. QUALITY MEDICAL REGULATIONS SERVICES (QMRS) OTTAWA, ONTARIO, CANADA HEALTH.

Slides:



Advertisements
Similar presentations
Quality Assurance Processes for TB Drugs. GDF Quality Assurance Processes.
Advertisements

Health Products and Food Branch Direction générale des produits de santé et des aliments The Canadian Medical Devices Regulatory Program CESO Conference.
Biopharmaceutical Quality
BACKGROUND: The Directorate General of Drug Administration under the Ministry of Health & Family Welfare, Government of the People's Republic of Bangladesh,
Medsafe – GMP update / release for supply / communicating quality issues Derek Fitzgerald Manager, Compliance Management 11 July 2013 RACI Pharmaceutical.
GMP Document and Record Retention
Slide 1 of 19D.K. Mubangizi, Dar Es Salaam Sept Training Workshop for Evaluators from National Medicines Regulatory Authorities in East African Community.
Feed Laws & Labeling AnSci Lance Baumgard
GOOD MANUFACTURING PRACTICES Training about our Food Safety Plan
Proposed Rules to Help Ensure the Safety of Imported Food 1.
Hazard Analysis Critical Control Point (HACCP)
Huzairy Hassan School of Bioprocess Engineering UniMAP.
World Health Organization
Current Good Manufacturing Practices (cGMP’s). Biotechnology using living cells and materials produced by cells to create pharmaceutical, diagnostic,
Canada Consumer Product Safety Act An Overview Graham Stewart Health Canada.
New Zealand Medicines and Medical Devices Safety Authority A business unit of the Ministry of Health.
Good Manufacturing Practices
Good Manufacturing Practice. Good Manufacturing Practice Regulations Establishes minimum GMP for methods to be used, and the facilities or controls to.
Support Programs version 2 March 2010 Cleaning and Sanitation
Best Practices: Where Industry Should Lead on Ensuring Proper Testing & Auditing Stephen F. Sundlof, DVM, PhD Senior Advisor for Animal and Food Safety.
What Are They? Who Needs them? What Are They? Who Needs them?
© Siemens AG 2014 Alle Rechte vorbehalten.siemens.com/lowvoltage New Legislative Framework (NLF) Sektor Infrastructure & Cities | Division Low and Medium.
Impact of FSMA on the Regulation of Domestic and Imported Animal Food by Daniel G. McChesney, Ph.D. at Wild Bird Feeding Industry 2011 Annual Meeting Naples,
Important informations
Final Rule for Preventive Controls for Human Food September 16, THE FUTURE IS NOW 1.
Proposed Rule for Preventive Controls for Animal Food.
Proposed Rule: 21 CFR 507 Proposed Rule for Preventive Controls for Animal Food 1.
30/02/2008 Dept. of Pharmaceutics 1 Salient Features of Quality Assurance Dr. Basavaraj K. Nanjwade M.Pharm., Ph.D Associate Professor Department of Pharmaceutics.
Dispensary and Administration Site Information Presentation.
1 1 Poultry Slaughter Exemptions Under the Federal Poultry Products Inspection Act and the SC Poultry Products Inspection Law SC Poultry Products Inspection.
Final Rule for Preventive Controls for Animal Food 1 THE FUTURE IS NOW.
Authorization and Inspection of Cyclotron Facilities The Authorization Process.
Module 14Slide 1 of 23 WHO - EDM Basic Principles of GMP Active Pharmaceutical Ingredients Part Three, 18.
1 A Seminar On Pharmaceutical Outsourcing A Seminar On Pharmaceutical Outsourcing.
FAS Training 2016 SMR 4 Food and Feed Hygiene Carrick on Shannon, Charleville, Kilkenny Integrated Controls Division 1.
Good Manufacturing Practice (GMP) Compliance: GMPs EXPLAINED.
GMP AND cGMP CONSIDERATIONS
Pass Regulatory Affairs Certification (RAC) Global Scope exam in just 24 HOURS! 100% REAL EXAM QUESTIONS ANSWERS Regulatory Affairs Certification (RAC)
1 CHALLENGES IN REGULATING QUALITY AND RATIONAL USE OF ANTIBIOTICS ALLIANCE FOR THE PRUDENT USE OF ANTIBIOTICS: INAGURAL MEETING COURTYARD.
Quality Control significance in pharmaceutical industry
CM&C Inspections The Pre-Approval Inspection (PAI) in the US 27 May 2010.
Final Rule for Sanitary Transportation. Background Proposed Rule: February 5, 2014 Public Comments: More than 200 Final Rule: On Display April 5, 2016.
Veterinary Products Management and Quality Control System in Thailand : Veterinary Vaccine Tasanee Lorchaivej Workshop on the Veterinary Products.
Responsibilities of Sponsor, Investigator and Monitor
RAC Regulatory Affairs Certification
LABORATORY SAMPLES AND CONTRACT MANAGEMENT
Author: Nurul Azyyati Sabri
GD211 Training Module 5 Conclusions.
GOOD MANUFACTURING PRACTICE FOR BIOPROCESS ENGINEERING (ERT 425)
Responsibilities of Sponsor, Investigator and Monitor
Final Rule for Preventive Controls for Human Food
Hazard Analysis Critical Control Point (HACCP).
Nonsterile compounding-USP ch 795
PREPARATION OF GMP REPORT
PREPARATION FOR GMP INSPECTION
Hazard Analysis Critical Control Point (HACCP)
Food Production Systems
Assuring Quality Care for Animals Youth Food Animal Quality Assurance
Nonsterile compounding-USP ch 795
Introduction to GMP.
Nonsterile compounding-USP ch 795
GMP Inspection Process
GMP Inspection Process
GMP Inspection Process
Natural and Non-prescription Health Products Directorate (NNHPD)
PREREQUISITE PROGRAMS
EU Food Safety Requirements: - Hygiene of Foodstuffs -
Compounded Drugs and Lack of Premarket FDA-Approval
Final Rule on Foreign Supplier Verification Programs
Panel discussion GMP inspection process – Health Canada
Presentation transcript:

PRESENTED BY DR. JALAL MOKHALALATI, B.SC., M.SC., PH.D. QUALITY MEDICAL REGULATIONS SERVICES (QMRS) OTTAWA, ONTARIO, CANADA HEALTH CANADA: Natural Health PRODUCTS REGULATIONS SITE LICENSING 9/17/2014www.qmrs.com 1

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING Objective: The objective of this presentation is to provide attendees with some essential information on HC Natural Health products regulations and site licensing process 9/17/2014www.qmrs.com 2

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING Background All NHPs sold in Canada are subject to the Natural Health Products Regulations, which came into force on January 1, To get product and site licenses, specific labelling and packaging requirements must be met, GMPs must be followed, and proper safety and efficacy evidence must be provided. 9/17/2014www.qmrs.com 3

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING What are natural health products? Natural health products (NHPs) are naturally occurring substances that are used to restore or maintain good health. They are often made from plants, but can also be made from animals, microorganisms and marine sources. They come in a wide variety of forms like tablets, capsules, tinctures, solutions, creams, ointments and drops. 9/17/2014www.qmrs.com 4

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING NHPs (complementary or alternative medicines, include: Vitamins and minerals Herbal remedies Traditional and Homeopathic medicines Probiotics Other products like amino acids and essential fatty acids 9/17/2014www.qmrs.com 5

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING NHPs are used and marketed for a number of health reasons, like the prevention or treatment of an illness or condition, the reduction of health risks, or the maintenance of good health. They must be safe to be used as over-the- counter products. Products needing a prescription are regulated as drugs. 9/17/2014www.qmrs.com 6

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING Are there risks to using NHPs? While NHPs are generally safe, they are not risk free. Risks include: Manufacturing problems (Such as contamination, or incorrect ingredients) Unproven claims, which can lead people to use the wrong products for serious conditions 9/17/2014www.qmrs.com 7

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING Are there risks to using NHPs? Not enough information for people to make an informed choice (like incorrect instructions or no warnings that a product may not be suitable for certain groups) Interaction with others prescription drugs Unwanted side effects 9/17/2014www.qmrs.com 8

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING NHPs Marketing authorization? To be licensed in Canada, NHPs must be safe, effective, of high quality and carry detailed label information People can identify products that have been licensed for sale in Canada by looking for the eight-digit Natural Product Number (NPN) on the label. A NPN means that the product has been authorized for sale in Canada and is safe and effective 9/17/2014www.qmrs.com 9

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING HC Approval: NPN 9/17/2014www.qmrs.com 10

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING HC Licensing Requirements : 1. Product licensing 2. Evidence requirements for safety and efficacy 3. Site licensing 4. Good Manufacturing Practices 9/17/2014www.qmrs.com 11

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING Product licensing All NHPs must have a product license before they can be sold in Canada. To get a license, applicants must give detailed information about the product to Health Canada, including: medicinal ingredients, source, dose, potency, non- medicinal ingredients and recommended use(s). 9/17/2014www.qmrs.com 12

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING Evidence requirements for safety and efficacy The safety and efficacy of NHPs and their health claims must be supported by proper evidence so that consumers and HC know the products are safe and effective. The type and amount of supporting evidence required depends on the proposed health claim of the product and its overall risks. 9/17/2014www.qmrs.com 13

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING Site licensing All Canadian manufacturers, packagers, labelers, and importers of NHPs must have site licenses. To get a license, sites must maintain proper distribution records, have proper procedures for product recalls and for the handling, storage and delivery of their products, and demonstrate that they meet GMPs requirements. 9/17/2014www.qmrs.com 14

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING What is a Site Licence? The Regulations requires a manufacturer, packager, labeler, and importer of NHPs to hold a valid site licence. A site licence issued by the NHPD gives the licensee authorization to conduct these activities. These activities must be carried out according to the GMPs outlined under the Regulations. 9/17/2014www.qmrs.com 15

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING Good Manufacturing Practices (GMPs) Good Manufacturing Practices for NHPs cover: product specifications, premises, equipment, personnel, sanitation program, operations, quality assurance, stability, records, batch samples, and recall reporting 9/17/2014www.qmrs.com 16

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING Purpose of the Site Licence Regulations To ensure that HC is aware of all sites that are manufacturing, packaging, labelling, and importing NHPs in Canada. To set the requirement that businesses assure HC that they are meeting the regulatory requirements related to GMP To ensure that all NHPs are safe, of good quality, and are produced & stored in sites that comply with the GMP Regulations. 9/17/2014www.qmrs.com 17

H EALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING Who Requires a Site Licence? A site licence is required for the physical site in Canada where any persons or businesses wish to manufacture, package, label, and/or import a NHP for sale. 9/17/2014www.qmrs.com 18

H EALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING Notes on Importing NHPs:  Any business or individual that brings into Canada a NHP for the purpose of sale is considered to be an importer.  Importers that ship a product directly to the retailer without first storing the product require a site licence  Retailers selling products that they themselves have imported are considered importers 9/17/2014www.qmrs.com 19

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING Applying for a Site Licence Applicants must provide evidence of GMP compliance in the form of one of the following:  Audit Report from a NHPD recognized third party  Quality Assurance Report (QAR) Form  Drug Establishment Licence (DEL):  Certificate of Compliance (CoC) or inspection report issued by a Regulatory Authority from a country for which HC presently has a mutual recognition agreement (MRA)  GMP Certificate from a Qualified Authority 9/17/2014www.qmrs.com 20

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING Submission Management Screening & Assessment of the Application Applications meeting administrative requirements will be assigned a file number and a submission number. The NHPD aims to complete a site licence application within 45 days from the date of receipt to the date of issuance of the site licence or refusal. 9/17/2014www.qmrs.com 21

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING Deficiencies in the Application Deficiencies in the application can range from minor and easily correctable to major or critical, There are four types of deficiencies:  Administrative deficiencies  Minor deficiencies  Major deficiencies  Critical deficiencies 9/17/2014www.qmrs.com 22

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING Site Licence Issuance: The NHPD will only issue or amend a site licence when the applicant has submitted a complete submission with all the required supporting information to assess whether the site is fully compliant with the Regulations. 9/17/2014www.qmrs.com 23

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING Refusal to Issue a Site Licence: The NHPD may refuse to issue or amend a site licence when the site is not compliant with the GMP requirements When the application is deficient, When the applicant does not provide additional information on request, or When the information submitted is false or misleading. 9/17/2014www.qmrs.com 24

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING Products Manufactured, Packaged and Labelled at Foreign Sites Canadian importers must be licensed and the onus is on them to provide evidence that imported products come from sites that meet Canadian GMPs or equivalent standards. Importers may submit either an Audit Report from third party or a QAR or any of the following of for their foreign sites: 9/17/2014www.qmrs.com 25

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING 1.Foreign Site Reference Number (FSRN) Authorization Form: A FSRN authorization form signed and dated by the Senior Official indicated for that company. FSRN's are issued to sites that have demonstrated compliance to GMPs Regulations via the FSRN application process. 9/17/2014www.qmrs.com 26

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING 2. Certificate of Compliance (CoC) Or inspection report (including corrective actions taken) issued by a Regulatory Authority from a country for which the HC Inspectorate presently has a mutual recognition agreement (MRA) related to GMP. 9/17/2014www.qmrs.com 27

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING 3. Good Manufacturing Practices Certificate or inspection report (including the corrective actions taken) from a Qualified Authority. A qualified authority is an authority member of the Pharmaceutical Inspection Cooperation Scheme (PIC/S) or the United States Food and Drug Administration (USFDA). 9/17/2014www.qmrs.com 28

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING Licence Expiry and Renewal The site licence must be renewed as follows: 1. Every year, for the first three years 2. Every two years, when the licensee has held the licence for three years from the date of issuance but less than nine years. 3. Every three years, when the licensee has held the licence for nine years from the date of issuance or more. 9/17/2014www.qmrs.com 29

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING Licence Amendment An amendment is required when: Adding a new activity. Adding a new building Changing from manufacturing, packaging, labelling, or importing a non-sterile dosage form to sterile dosage form. Adding a new foreign site. 9/17/2014www.qmrs.com 30

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING Licence Suspension and Cancellation HC may suspend a site licence when: The licensee is found to have contravened the Regulations When licensee make a false or misleading statement in the application When HC has enough evidence to believe that it is necessary to suspend the licence to prevent consumers injury. 9/17/2014www.qmrs.com 31

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING 9/17/2014www.qmrs.com 32 To Conclude: A site wishing to obtain a SL must demonstrate that requirements for GMP have been met. To demonstrate GMP compliance, the site will need to provide evidence that its buildings, equipment, procedures and proposed practices meet the requirements A Canadian importer must provide satisfactory evidence that the foreign site meets the Canadian GMP requirements required by the Canadian regulations

HEALTH CANADA: NATURAL HEALTH PRODUCTS REGULATIONS SITE LICENSING For Any Questions Please Contact: Dr. Jalal Mokhalalati 9/17/2014www.qmrs.com 33